Greenberger M J, Strieter R M, Kunkel S L, Danforth J M, Laichalk L L, McGillicuddy D C, Standiford T J
Department of Medicine, University of Michigan Medical School, Ann Arbor, USA.
J Infect Dis. 1996 Jan;173(1):159-65. doi: 10.1093/infdis/173.1.159.
The role of macrophage inflammatory protein-2 (MIP-2) in bacterial pneumonia was characterized. Mice were challenged with Klebsiella pneumoniae intratracheally, and organs were harvested at 8, 24, and 48 h. Inoculation with K. pneumoniae resulted in the time-dependent expression of MIP-2 mRNA and protein within the lung, which was maximal 48 h after inoculation. Mice were then passively immunized with rabbit anti-murine MIP-2 serum intraperitoneally 2 h before administration of K. pneumoniae. Treatment with anti-MIP-2 serum resulted in a 60% decrease in lung neutrophil (PMNL) influx and a significant increase in K. pneumoniae colony-forming units in both lung and liver homogenates. Finally, treatment with anti-MIP-2 serum decreased early (48-72 h) but not late (after 72 h) survival in animals with Klebsiella pneumonia. This study indicates that MIP-2 is produced during Klebsiella pneumonia and inhibition of MIP-2 bioactivity in vivo results in decreased PMNL influx and lung bacterial clearance in murine Klebsiella pneumonia. MIP-2 is produced during Klebsiella pneumonia and inhibition of MIP-2 bioactivity in vivo results in decreased PMNL influx and lung bacterial clearance in murine Klebsiella pneumonia.
研究了巨噬细胞炎性蛋白-2(MIP-2)在细菌性肺炎中的作用。将小鼠经气管内接种肺炎克雷伯菌,分别于接种后8小时、24小时和48小时采集器官。接种肺炎克雷伯菌导致肺内MIP-2 mRNA和蛋白表达呈时间依赖性,接种后48小时达到峰值。然后在接种肺炎克雷伯菌前2小时,给小鼠腹腔内被动注射兔抗小鼠MIP-2血清。抗MIP-2血清治疗导致肺中性粒细胞(PMNL)流入减少60%,肺和肝匀浆中肺炎克雷伯菌集落形成单位显著增加。最后,抗MIP-2血清治疗降低了肺炎克雷伯菌肺炎动物的早期(48 - 72小时)生存率,但未降低晚期(72小时后)生存率。这项研究表明,在肺炎克雷伯菌肺炎期间会产生MIP-2,体内抑制MIP-2生物活性会导致小鼠肺炎克雷伯菌肺炎中PMNL流入减少和肺细菌清除率降低。在肺炎克雷伯菌肺炎期间会产生MIP-2,体内抑制MIP-2生物活性会导致小鼠肺炎克雷伯菌肺炎中PMNL流入减少和肺细菌清除率降低。